Gross Margin
26.53%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 24.13%.Updated Aug 20, 2026Profit Margin
8.26%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Margin
14.82%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Assets (TTM)
4.33%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Equity (TTM)
11.61%vs Specialty Chemicals peers Updated Aug 20, 2026Revenue (TTM)
3.22BTWD100.92M · vs all stocks (USD) Updated Aug 20, 2026Revenue per Share (TTM)
37.62TWDUpdated Aug 20, 2026Quarterly Revenue Growth
27.90%vs Specialty Chemicals peers Updated Aug 20, 2026Gross Profit (TTM)
776.18MTWD24.36M · vs all stocks (USD) Updated Aug 20, 2026EBITDA (TTM)
439.52MTWD13.79M · vs all stocks (USD) Updated Aug 20, 2026Net Income (TTM)
265.51MTWD8.33M · vs all stocks (USD) Updated Aug 20, 2026Quarterly Earnings Growth (YoY)
61645.30%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Cash Flow (TTM)
347.62MTWD10.91M · vs all stocks (USD) Updated Aug 20, 2026Levered Free Cash Flow (TTM)
177.11MTWD5.56M · vs all stocks (USD) Updated Aug 20, 2026Forward Annual Dividend Rate
0.9900TWDUpdated Aug 20, 2026Forward Annual Dividend Yield
0.49%Updated Aug 20, 2026Trailing Annual Dividend Rate
1.00TWDUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.49%Updated Aug 20, 2026Payout Ratio
32.24%vs Specialty Chemicals peers Updated Aug 20, 2026Minority Interest (Equity)
4.33MTWDFY2025 · Dec 31, 2025Revenue
2.85BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
2.29BTWDFY2025 · Dec 31, 2025Gross Profit
564.86MTWDFY2025 · Dec 31, 2025Operating Income
166.29MTWD5.22M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
150.60MTWDFY2025 · Dec 31, 2025Income Tax Expense
43.23MTWDFY2025 · Dec 31, 2025Net Income
107.37MTWDFY2025 · Dec 31, 2025EBIT
192.60MTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
369.81MTWDFY2025 · Dec 31, 2025Research & Development
66.66MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
374.51MTWDFY2025 · Dec 31, 2025Other Operating Expenses
-42.60MTWDFY2025 · Dec 31, 2025Non-operating Interest Income
11.49MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
42.00MTWDFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.83MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
161.26MTWDFY2025 · Dec 31, 2025Free Cash Flow
131.64MTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.10BTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
150.60MTWDFY2025 · Dec 31, 2025Other Non-cash Items
30.51MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
69.95MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-89.79MTWDFY2025 · Dec 31, 2025Capital Expenditures
-29.62MTWDFY2025 · Dec 31, 2025Net Intangibles (CF)
-55.00KTWDFY2025 · Dec 31, 2025Purchase of Investments
-245.16MTWDFY2025 · Dec 31, 2025Other Investing Activity
-1.97MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
-276.75MTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-252.21MTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
116.72MTWDFY2025 · Dec 31, 2025Other Financing Charges
-4.70MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
-140.19MTWDFY2025 · Dec 31, 2025